☆ 4.2 Article

Developing Precision Medicine for Bladder Cancer

HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2021)

Get Full Text
Add to Collection

Journal

HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
Volume 35, Issue 3, Pages 633-653

Publisher

W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1016/j.hoc.2021.02.008

Keywords

Precision medicine; Bladder cancer; Urothelial carcinoma; Targeted therapy; Biomarkers; Immunotherapy; Chemotherapy

Categories

Oncology Hematology

Funding

  1. Memorial Sloan Kettering's NIH/NCI Cancer Center Support Grant [P30 CA008748]
  2. NIH/NCI award [T32-CA009207]
  3. MSK's NCI SPORE in Bladder Cancer [P50 CA221745-01]
  4. DOD Congressionally Directed Medical Research Program Translational Team Science Award
  5. NCI Biomarker, Imaging and Quality of Life Studies Funding Program (BIQSFP)

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.